A real-world descriptive study of screening practices for hydroxychloroquine retinopathy in Japan using an insurance claims database

A real-world descriptive study of screening practices for hydroxychloroquine retinopathy in Japan using an insurance claims database

Abstract Since 2015, hydroxychloroquine (HCQ) has been widely used as a standard treatment for systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE) under the national health insurance system in Japan. However, the status of routine ophthalmological screening for retinopathy, wh...

Full description

Saved in:
Bibliographic Details
Main Authors: Kumiko Kato, Kei Shinoda, Naoto Yokogawa, Takumi Tajima, Toshiya Takahashi, Mineo Kondo
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Hydroxychloroquine
Ophthalmological screening
Lupus erythematosus
Retinopathy
Safety
Online Access:https://doi.org/10.1038/s41598-025-96579-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-96579-2

Similar Items